用于帕金森病管理的可溶性微阵列勒沃多巴和卡比多巴贴片
Qonita Kurnia Anjani1, Natalia Moreno-Castellanos2, Yaocun Li3
1School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK; Fakultas Farmasi, Universitas Megarezky, Jl. Antang Raya No. 43, Makassar 90234, Indonesia.
概括
新型溶解微阵列贴片 (MAPs) 提供了改善的卡比多巴和乐伏多巴的通过皮肤传递,增强了帕金森病的治疗效果. 这些贴片显示出有希望的疗效和生物相容性,用于有效的药物输送.
科学领域:
- 制药科学 制药科学
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
背景情况:
- 口服卡比多巴和乐伏多巴是帕金森病的标准治疗方法,但面临着快速降解和胃肠道问题等挑战.
- 这些局限性需要使用替代药物输送方法来提高治疗疗效和患者的服药性.
- 通过皮肤输送提供了一个潜在的解决方案,以克服口服药物的药理动力学和药理动力学限制.
研究的目的:
- 开发和评估新型溶解微阵列贴片 (MAPs),以增强卡比多巴和莱沃多巴的通过皮肤输送.
- 评估制造的MAP的机械性能,皮肤插入能力和ex vivo药物递送效率.
- 确认用于皮肤应用的MAPs的生物相容性.
主要方法:
- 使用Tween® 80来改善皮肤透射性质,制造装载有卡比多巴和勒沃多巴的溶解微阵列贴片 (MAP).
- 评估MAP的机械强度和插入深度到切割的新生猪皮肤中.
- 在24小时内量化药物递送效率的ex vivo皮肤动力学研究.
- 使用人类皮肤纤维细胞进行体外生物相容性测试.
主要成果:
- MAP表现出足够的机械强度 (承受32N压力),并且在猪皮中实现了高达650微米的插入深度.
- 活体研究表明,通过皮肤递送的效率显著:约为利沃多巴的53.35%,卡比多巴的40.14%在24小时内.
- 生物相容性评估证实了MAP与人类皮肤纤维细胞细胞的可接受细胞相容性.
结论:
- 溶解含有卡比多巴和勒沃多巴的MAP是通过皮肤递送药物的有前途的新战略.
- 这种方法为口服提供了潜在的替代方案,旨在改善帕金森病的管理.
- 制造的MAP显示了有效和安全的皮肤应用的有利特性.
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
01:22Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338
01:30Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K